Project Details
Projekt Print View

Antiviral Activity of Guanylate-Binding Proteins and Viral Countermeasures

Subject Area Virology
Term from 2018 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 400912104
 
Final Report Year 2022

Final Report Abstract

In the present project, we significantly advanced our understanding on the role of GBP proteins as antiviral restriction factors. We found that both GBP2 and GBP5 inhibit many viral pathogens by interfering with furin-mediated processing of their glycoproteins. We also obtained first evidence that GBP2 and GBP5 restrict SARS-CoV-2. In addition, we determined critical domains and structural requirements of their antiviral activity. Finally, we found that GBP2 and GBP5 are expressed under the control of endogenous retroviral RNAs and induced upon HIV-1 infection. Other results provide novel insights into the induction and inhibitory action of innate antiviral mechanisms. They also revealed that some innate antiviral effectors target cellular virus dependency factors rather than the virus directly. Finally, they identified an interesting example of how human cells might exploit endogenized retroviral LTR to produces antiviral factors upon infection with current viral pathogens. Altogether, we feel that the project yielded interesting results but also opened prospects for future studies.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung